Trial intelligence / Profile preview

MENP: Metabolic Effects of BNP

NCT03397966Phase 4Terminated

Sponsor
VA Office of Research & Development
Start
Jul 2018
Primary completion
May 2019
Countries
1
01

Overview

A Phase 4 trial of nesiritide in obesity, sponsored by VA Office of Research & Development. Started Jul 2018; status: terminated.

02

Drugs

nesiritide
03

Conditions

obesity

Beyond the preview

Go deeper on NCT03397966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03397966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call